1. Home
  2. OPK vs MFA Comparison

OPK vs MFA Comparison

Compare OPK & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • MFA
  • Stock Information
  • Founded
  • OPK 2007
  • MFA 1997
  • Country
  • OPK United States
  • MFA United States
  • Employees
  • OPK N/A
  • MFA N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • MFA Real Estate Investment Trusts
  • Sector
  • OPK Health Care
  • MFA Real Estate
  • Exchange
  • OPK Nasdaq
  • MFA Nasdaq
  • Market Cap
  • OPK 1.0B
  • MFA 1.1B
  • IPO Year
  • OPK 1995
  • MFA N/A
  • Fundamental
  • Price
  • OPK $1.39
  • MFA $9.86
  • Analyst Decision
  • OPK Buy
  • MFA Buy
  • Analyst Count
  • OPK 4
  • MFA 8
  • Target Price
  • OPK $2.75
  • MFA $11.50
  • AVG Volume (30 Days)
  • OPK 2.0M
  • MFA 1.0M
  • Earning Date
  • OPK 11-06-2025
  • MFA 11-05-2025
  • Dividend Yield
  • OPK N/A
  • MFA 14.60%
  • EPS Growth
  • OPK N/A
  • MFA 41.64
  • EPS
  • OPK N/A
  • MFA 0.88
  • Revenue
  • OPK $664,029,000.00
  • MFA $284,489,000.00
  • Revenue This Year
  • OPK N/A
  • MFA N/A
  • Revenue Next Year
  • OPK $0.84
  • MFA $16.86
  • P/E Ratio
  • OPK N/A
  • MFA $11.21
  • Revenue Growth
  • OPK N/A
  • MFA 9.37
  • 52 Week Low
  • OPK $1.11
  • MFA $7.85
  • 52 Week High
  • OPK $2.04
  • MFA $13.45
  • Technical
  • Relative Strength Index (RSI)
  • OPK 51.88
  • MFA 45.84
  • Support Level
  • OPK $1.34
  • MFA $10.15
  • Resistance Level
  • OPK $1.44
  • MFA $10.57
  • Average True Range (ATR)
  • OPK 0.04
  • MFA 0.19
  • MACD
  • OPK -0.00
  • MFA -0.06
  • Stochastic Oscillator
  • OPK 50.00
  • MFA 1.39

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

Share on Social Networks: